ERBB2 alterations were frequently discordant (12/30, 40%) in patient matched primary and metastatic tumor pairs, with 5 tumors having ERBB2 alterations exclusive to the primary tumor and 7 ERBB2 alterations exclusive to the metastasis27. The gene discussed is ERBB2; the disease is metastatic neoplasm.